Workflow
华北制药(600812) - 2022 Q1 - 季度财报
NCPCNCPC(SH:600812)2022-04-27 16:00

Financial Performance - The company's operating revenue for Q1 2022 was ¥2,543,401,447.14, representing a decrease of 6.25% compared to the same period last year[6]. - The net profit attributable to shareholders of the listed company was ¥13,681,778.22, with a net profit excluding non-recurring gains and losses of ¥8,752,350.95[6]. - The basic earnings per share for the period was ¥0.008, with diluted earnings per share also at ¥0.008[9]. - Total operating revenue for Q1 2022 was CNY 2,543,401,447.14, a decrease of 6.23% from CNY 2,712,983,676.41 in Q1 2021[30]. - Net profit for Q1 2022 was CNY 19,196,750.52, compared to a net loss of CNY 53,837,904.06 in Q1 2021[32]. - Earnings per share for Q1 2022 was CNY 0.008, recovering from a loss of CNY 0.035 in Q1 2021[34]. - The company reported a total comprehensive income of CNY 18,827,920.61 for Q1 2022, compared to a loss of CNY 53,645,616.91 in Q1 2021[34]. - Operating profit for Q1 2022 increased to approximately ¥68.17 million, up 33.7% from ¥51.01 million in Q1 2021[48]. - Net profit for Q1 2022 was approximately ¥64.53 million, compared to ¥51.01 million in Q1 2021, reflecting a growth of 26.5%[48]. Cash Flow and Liquidity - The net cash flow from operating activities was ¥37,265,495.04, down by 11.82% year-on-year[6]. - Cash received from sales of goods and services in Q1 2022 was CNY 2,016,755,498.20, an increase from CNY 1,758,014,929.49 in Q1 2021[34]. - The net cash flow from operating activities was 37,265,495.04 RMB, a decrease from 42,262,764.11 RMB in the previous period, reflecting a decline of approximately 11.8%[37]. - The company reported a significant increase in cash paid for purchasing goods and services, which rose to 1,047,043,423.62 RMB from 791,977,612.37 RMB, an increase of about 32.1%[37]. - The cash outflow for investment activities was 106,179,314.59 RMB, compared to 139,510,714.82 RMB, showing a decrease of approximately 23.8%[37]. - Cash and cash equivalents at the end of Q1 2022 were approximately ¥2.12 billion, down from ¥2.84 billion at the end of Q1 2021[51]. - The company reported a net cash outflow from financing activities of approximately ¥961.60 million in Q1 2022, compared to a net inflow of ¥327.50 million in Q1 2021[51]. Assets and Liabilities - Total assets at the end of the reporting period were ¥25,158,030,067.03, an increase of 0.91% from the end of the previous year[9]. - The equity attributable to shareholders of the listed company was ¥6,100,944,277.42, reflecting a 0.25% increase from the end of the previous year[9]. - Total liabilities as of the end of the reporting period were CNY 18,119,821,232.27, compared to CNY 17,912,703,964.04 at the end of the previous period[30]. - The total liabilities decreased from approximately ¥13.44 billion in the previous year to ¥13.21 billion in Q1 2022[45]. - The total equity increased to approximately ¥6.91 billion in Q1 2022, up from ¥6.84 billion in the same period last year[45]. - Current liabilities totaled ¥14.67 billion, compared to ¥14.24 billion in the previous year, reflecting an increase of about 3.01%[26]. - Short-term borrowings increased to ¥8.02 billion from ¥7.63 billion, showing a rise of approximately 5.22%[26]. - Non-current liabilities, including long-term borrowings, decreased to ¥2.85 billion from ¥3.30 billion, a decline of about 13.52%[26]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 81,593[14]. - The largest shareholder, Jizhong Energy Co., Ltd., held 413,080,473 shares, representing 24.08% of the total shares[14]. Research and Development - Research and development expenses for Q1 2022 were CNY 33,337,722.55, up from CNY 28,364,300.05 in Q1 2021, indicating increased investment in innovation[32]. - Research and development expenses for Q1 2022 were approximately ¥4.37 million, a slight increase from ¥4.05 million in Q1 2021[48]. Inventory and Receivables - Accounts receivable increased to ¥2.28 billion from ¥1.96 billion year-over-year, indicating a growth of about 16.43%[22]. - Inventory levels rose to ¥2.44 billion, up from ¥2.39 billion, marking an increase of approximately 1.14%[22]. - The company’s inventory increased to 1,151,851,136.82 RMB from 1,117,477,202.18 RMB, reflecting a growth of approximately 3.1%[43].